Russell, James A <br/><br/>
Days alive and free as an alternative to a mortality outcome in pivotal vasopressor and septic shock trials.  [electronic resource] 

 -  Journal of critical care  10 2018 
 - 333-337 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-8615 
<br/><br/><label>Standard No.: </label>10.1016/j.jcrc.2018.05.003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Clinical Trials as Topic<br/>Dobutamine--therapeutic use<br/>Dopamine--therapeutic use<br/>Epinephrine--therapeutic use<br/>Humans<br/>Neurophysins--metabolism<br/>Norepinephrine--therapeutic use<br/>Protein Precursors--metabolism<br/>Randomized Controlled Trials as Topic<br/>Shock--mortality<br/>Shock, Septic--drug therapy<br/>Time Factors<br/>Treatment Outcome<br/>Vasoconstrictor Agents--therapeutic use<br/>Vasopressins--metabolism